Healthcare AI — Structured Engagement

90-Day Clinical AI Governance Pilot
for High-Risk AI Systems

Establish structured governance for high-risk clinical AI within 90 days.

Executive-level engagement. Structured implementation. Limited capacity.

For hospitals operating multiple AI systems influencing clinical decisions.

High-risk clinical AI systems require structured governance under the EU AI Act. Many hospitals deploy multiple AI vendors without a unified oversight framework. The 90-day pilot establishes a formal AI governance layer within one quarter — reducing regulatory exposure and strengthening executive accountability.

If requested today, could your organisation produce structured documentation of all high-risk AI systems within 24 hours?

If the answer is uncertain, governance exposure already exists.

High-risk AI systems require documented governance structures — not informal oversight.

Designed For

Designed for executive leadership.

CIO and CMIO leadership

Compliance and risk officers

Digital transformation directors

Hospitals deploying multiple AI vendors

Implementation Structure

Structured implementation within one quarter.

Phase 01

AI System Registry

Weeks 1–3

Inventory of AI systems influencing clinical decisions.

Vendor and departmental mapping.

Phase 02

High-Risk Classification

Weeks 3–6

Regulatory exposure mapping.

High-risk obligation matrix creation.

Phase 03

Oversight & Monitoring

Weeks 6–10

Human oversight workflow structure.

Incident tracking and documentation standardization.

Phase 04

Executive Reporting

Weeks 10–12

AI risk heatmap and gap analysis.

Board-ready governance documentation pack.

Each phase concludes with structured documentation and executive validation.

Day 90 Outcomes

Central AI system registry

High-risk classification matrix

Oversight control framework

Vendor documentation repository

Executive governance dashboard

Audit-ready documentation export

Designed to withstand internal audit and regulatory inquiry.

Beyond the Pilot

From pilot to continuous governance.

Upon completion of the pilot, institutions transition to continuous governance infrastructure including:

Continuous AI monitoring

Regulatory update integration

Executive dashboard maintenance

Ongoing documentation management

Executive Commitment

This engagement requires executive sponsorship and cross-department coordination.

Designed for institutions ready to formalize structured AI oversight.

Executive Rationale

Unstructured AI governance creates invisible exposure. Audit findings, regulatory inquiry, or board scrutiny convert that exposure into immediate operational risk.

The 90-day pilot establishes defensible governance before external review demands proof.

Investment

Pilot Investment

€40,000 – €85,000

Scaled to AI system volume and institutional complexity.

Comparable to a single external audit cycle — but establishes permanent governance capability.

Capacity is limited to ensure direct senior oversight.

Schedule Executive Discussion

Executive discussions are scheduled within 24 hours.

High-risk clinical AI oversight is becoming a board-level responsibility across EU healthcare systems.

Schedule an executive discussion to establish structured governance within one quarter.

LGA – Lifecycle Governance Agency

Operational Governance for AI & Robotics

Lifecycle Telehealth group BV

Trading as Lifecycle Governance Agency

Enterprise number: BE 0878.090.520

© 2026 Lifecycle Governance Agency. All rights reserved.

Lifecycle Governance Agency provides governance implementation and evidence-support services. It does not act as a regulator, notified body, certification body or legal adviser.

Clinical AI Registry™ is a proprietary framework of Lifecycle Governance Agency.